Skip to main content
Erschienen in: Surgery Today 12/2015

01.12.2015 | Original Article

Comparing diffusion-weighted imaging and positron emission tomography for pulmonary nodules measuring from 1 to 3 cm in size

verfasst von: Hiroaki Nomori, Yue Cong, Hiroshi Sugimura, Yoshiaki Kato

Erschienen in: Surgery Today | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

Purposes

To examine whether diffusion-weighted magnetic resonance imaging (DWI) is as useful as fluorodeoxyglucose positron emission tomography (FDG-PET) for discriminating between malignant and benign pulmonary nodules measuring less than 3 cm in size, as well as for predicting tumor aggressiveness.

Methods

PET and DWI were carried out on 87 pulmonary nodules measuring from 1 to 3 cm in size (66 NSCLCs and 21 benign nodules). The signal intensity (SI) of DWI was measured by the contrast ratio (CR) between the lesions and spinal cord, i.e. SI-CR. The maximum standard uptake value (SUV) of PET was measured by CR between the lesions and contralateral lung, i.e. SUV-CR.

Results

DWI and PET showed sensitivities of 0.86 and 0.71, and specificities of 0.90 and 0.81, respectively. While there was no significant difference in the specificity between the two, DWI showed a significantly higher sensitivity than PET (p = 0.013). While the difference in the sensitivity was significant in lung adenocarcinoma (p = 0.012), there was no difference in the other histological types. Both the SI-CR and SUV-CR were significantly higher in the tumors with either histological invasiveness or lymphatic metastasis than in those without.

Conclusions

DWI is thus considered to be useful, not only to diagnose NSCLCs, especially in lung adenocarcinoma, but also for predicting tumor aggressiveness as well as FDG-PET.
Literatur
1.
Zurück zum Zitat Higashi K, Nishikawa T, Seki H, Oguchi M, Nambu Y, Ueda Y, Yuasa K, Tonami H, Okimura T, Yamamoto I. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung cancer. J Nucl Med. 1998;39:1016–20.PubMed Higashi K, Nishikawa T, Seki H, Oguchi M, Nambu Y, Ueda Y, Yuasa K, Tonami H, Okimura T, Yamamoto I. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung cancer. J Nucl Med. 1998;39:1016–20.PubMed
2.
Zurück zum Zitat Cheran SK, Nielsen ND, Patz EF Jr. False-negative findings for primary lung tumors on FDG positron emission tomography: staging and prognostic implications. AJR. 2004;182:1129–32.CrossRefPubMed Cheran SK, Nielsen ND, Patz EF Jr. False-negative findings for primary lung tumors on FDG positron emission tomography: staging and prognostic implications. AJR. 2004;182:1129–32.CrossRefPubMed
3.
Zurück zum Zitat Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to CT images. Lung Cancer. 2004;45:19–27.CrossRefPubMed Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to CT images. Lung Cancer. 2004;45:19–27.CrossRefPubMed
4.
Zurück zum Zitat Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Kobayashi T, Uno K. Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1 N0 M0 lung adenocarcinoma. J Thorac Cardiovasc Surg. 2004;128:396–401.CrossRefPubMed Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Kobayashi T, Uno K. Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1 N0 M0 lung adenocarcinoma. J Thorac Cardiovasc Surg. 2004;128:396–401.CrossRefPubMed
5.
Zurück zum Zitat Watanabe K, Nomori H, Ohtsuka T, Naruke T, Ebihara A, Orikasa H, Yamazaki K, Uno K, Kobayashi T, Goya T. [F-18] Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas. Jpn J Clin Oncol. 2006;36:403–9.CrossRefPubMed Watanabe K, Nomori H, Ohtsuka T, Naruke T, Ebihara A, Orikasa H, Yamazaki K, Uno K, Kobayashi T, Goya T. [F-18] Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas. Jpn J Clin Oncol. 2006;36:403–9.CrossRefPubMed
6.
Zurück zum Zitat Imai K, Minamiya Y, Saito H, Motoyama S, Sato Y, Ito A, Yoshino K, Kudo S, Takashima S, Kawaharada Y, Kurihara N, Orino K, Ogawa J. Diagnostic imaging in the preoperative management of lung cancer. Surg Today. 2014;44:1197–206.CrossRefPubMed Imai K, Minamiya Y, Saito H, Motoyama S, Sato Y, Ito A, Yoshino K, Kudo S, Takashima S, Kawaharada Y, Kurihara N, Orino K, Ogawa J. Diagnostic imaging in the preoperative management of lung cancer. Surg Today. 2014;44:1197–206.CrossRefPubMed
7.
Zurück zum Zitat Goo JM, Im JG, Do KH, Yeo JS, Seo JB, Kim HY, Chung JK. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology. 2000;216:117–21.CrossRefPubMed Goo JM, Im JG, Do KH, Yeo JS, Seo JB, Kim HY, Chung JK. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology. 2000;216:117–21.CrossRefPubMed
8.
Zurück zum Zitat Wang J, Takashima S, Takayama F, Kawashima S, Saito A, Matsushita T, Momose M, Ishiyama T. Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology. 2001;220:621–30.CrossRefPubMed Wang J, Takashima S, Takayama F, Kawashima S, Saito A, Matsushita T, Momose M, Ishiyama T. Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology. 2001;220:621–30.CrossRefPubMed
9.
Zurück zum Zitat Sumi M, Takagi Y, Uetani M, Morikawa M, Hayashi K, Kabasawa H, Aikawa K, Nakamura T. Diffusion-weighted echoplanar MR imaging of salivary glands. AJR. 2002;178:959–65.CrossRefPubMed Sumi M, Takagi Y, Uetani M, Morikawa M, Hayashi K, Kabasawa H, Aikawa K, Nakamura T. Diffusion-weighted echoplanar MR imaging of salivary glands. AJR. 2002;178:959–65.CrossRefPubMed
10.
Zurück zum Zitat Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Rad Med. 2004;22:275–82. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Rad Med. 2004;22:275–82.
11.
Zurück zum Zitat Nasu K, Kuroki Y, Kuroki S, Murakami K, Nawano S, Moriyama N. Diffusion-weighted single shot echo planar imaging of colorectal cancer using a sensitivity-encoding technique. Jpn J Clin Oncol. 2004;34:620–6.CrossRefPubMed Nasu K, Kuroki Y, Kuroki S, Murakami K, Nawano S, Moriyama N. Diffusion-weighted single shot echo planar imaging of colorectal cancer using a sensitivity-encoding technique. Jpn J Clin Oncol. 2004;34:620–6.CrossRefPubMed
12.
Zurück zum Zitat Murakami R, Sugahara T, Nakamura H, Hirai T, Kitajima M, Hayashida Y, Baba Y, Oya N, Kuratsu J, Yamashita Y. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology. 2007;243:493–9.CrossRefPubMed Murakami R, Sugahara T, Nakamura H, Hirai T, Kitajima M, Hayashida Y, Baba Y, Oya N, Kuratsu J, Yamashita Y. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology. 2007;243:493–9.CrossRefPubMed
13.
Zurück zum Zitat Woodhams R, Matsunaga K, Kan S, Hata H, Ozaki M, Iwabuchi K, Kuranami M, Watanabe M, Hayakawa K. ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci. 2005;4:35–42.CrossRefPubMed Woodhams R, Matsunaga K, Kan S, Hata H, Ozaki M, Iwabuchi K, Kuranami M, Watanabe M, Hayakawa K. ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci. 2005;4:35–42.CrossRefPubMed
14.
Zurück zum Zitat Hayashida Y, Yakushiji T, Awai K, Katahira K, Nakayama Y, Shimomura O, Kitajima M, Hirai T, Yamashita Y, Mizuta H. Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: initial results. Eur Radiol. 2006;16:2637–43.CrossRefPubMed Hayashida Y, Yakushiji T, Awai K, Katahira K, Nakayama Y, Shimomura O, Kitajima M, Hirai T, Yamashita Y, Mizuta H. Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: initial results. Eur Radiol. 2006;16:2637–43.CrossRefPubMed
15.
Zurück zum Zitat Reinsberg SA, Payne GS, Riches SF, Ashley S, Brewster JM, Morgan VA, deSouza NM. Combined use of Diffusion-Weighted MRI and 1H MR Spectroscopy to Increase Accuracy in Prostate Cancer Detection. AJR. 2007;188:91–8.CrossRefPubMed Reinsberg SA, Payne GS, Riches SF, Ashley S, Brewster JM, Morgan VA, deSouza NM. Combined use of Diffusion-Weighted MRI and 1H MR Spectroscopy to Increase Accuracy in Prostate Cancer Detection. AJR. 2007;188:91–8.CrossRefPubMed
16.
Zurück zum Zitat Dzik-Jurasz A, Domenig C, George M, Wolber J, Padhani A, Brown G, Doran S. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet. 2002;360:307–8.CrossRefPubMed Dzik-Jurasz A, Domenig C, George M, Wolber J, Padhani A, Brown G, Doran S. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet. 2002;360:307–8.CrossRefPubMed
17.
Zurück zum Zitat Matoba M, Tonami H, Kondou T, Yokota H, Higashi K, Toga H, Sakuma T. Lung carcinoma: diffusion weighted MR imaging—preliminary evaluation with apparent diffusion coefficient. Radiology. 2007;243:570–7.CrossRefPubMed Matoba M, Tonami H, Kondou T, Yokota H, Higashi K, Toga H, Sakuma T. Lung carcinoma: diffusion weighted MR imaging—preliminary evaluation with apparent diffusion coefficient. Radiology. 2007;243:570–7.CrossRefPubMed
18.
Zurück zum Zitat Mori T, Nomori H, Ikeda K, Kawanaka K, Shiraishi S, Katahira K, Yamashita Y. Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography. J Thorac Oncol. 2008;3:358–64.CrossRefPubMed Mori T, Nomori H, Ikeda K, Kawanaka K, Shiraishi S, Katahira K, Yamashita Y. Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography. J Thorac Oncol. 2008;3:358–64.CrossRefPubMed
19.
Zurück zum Zitat Ohba Y, Nomori H, Mori T, Ikeda K, Shibata H, Kobayashi H, Shiraishi S, Katahira K. Is diffusion-weighted magnetic resonance imaging superior to fluorodeoxyglucose-positron emission tomography in non-small cell lung cancer? J Thorac Cardiovasc Surg. 2009;138:439–45.CrossRefPubMed Ohba Y, Nomori H, Mori T, Ikeda K, Shibata H, Kobayashi H, Shiraishi S, Katahira K. Is diffusion-weighted magnetic resonance imaging superior to fluorodeoxyglucose-positron emission tomography in non-small cell lung cancer? J Thorac Cardiovasc Surg. 2009;138:439–45.CrossRefPubMed
20.
Zurück zum Zitat Nomori H, Mori T, Ikeda K, Kawanaka K, Shiraishi S, Katahira K, Yamashita Y. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. J Thorac Cardiovasc Surg. 2008;135:816–22.CrossRefPubMed Nomori H, Mori T, Ikeda K, Kawanaka K, Shiraishi S, Katahira K, Yamashita Y. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. J Thorac Cardiovasc Surg. 2008;135:816–22.CrossRefPubMed
21.
Zurück zum Zitat Ohno Y, Koyama H, Onishi Y, Takenaka D, Nogami M, Yoshikawa T, Matsumoto S, Kotani Y, Sugimura K. Non-small cell lung cancer: whole-body MR examination for M-stage assessment—utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology. 2008;248:643–54.CrossRefPubMed Ohno Y, Koyama H, Onishi Y, Takenaka D, Nogami M, Yoshikawa T, Matsumoto S, Kotani Y, Sugimura K. Non-small cell lung cancer: whole-body MR examination for M-stage assessment—utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology. 2008;248:643–54.CrossRefPubMed
22.
Zurück zum Zitat Komori T, Narabayashi I, Matsumura K, Matsuki M, Akagai H, Ogura Y, Aga F, Adachi I. 2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience. Ann Nucl Med. 2007;21:209–15.CrossRefPubMed Komori T, Narabayashi I, Matsumura K, Matsuki M, Akagai H, Ogura Y, Aga F, Adachi I. 2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience. Ann Nucl Med. 2007;21:209–15.CrossRefPubMed
23.
Zurück zum Zitat Lichy MP, Aschoff P, Plathow C, Stemmer A, Horger W, Mueller W, Steidle G, Horger M, Schafer J, Eschmann SM, Kiefer B, Claussen CD, Pfannenberg C, Schlemmer HP. Tumor detection by diffusion-weighted MRI and ADC-mapping—initial clinical experiences in comparison to PET-CT. Invest Radiol. 2007;42:605–13.CrossRefPubMed Lichy MP, Aschoff P, Plathow C, Stemmer A, Horger W, Mueller W, Steidle G, Horger M, Schafer J, Eschmann SM, Kiefer B, Claussen CD, Pfannenberg C, Schlemmer HP. Tumor detection by diffusion-weighted MRI and ADC-mapping—initial clinical experiences in comparison to PET-CT. Invest Radiol. 2007;42:605–13.CrossRefPubMed
24.
Zurück zum Zitat Uto T, Takehara Y, Nakamura Y, Naito T, Hashimoto D, Inui N, Suda T, Nakamura H, Chida K. Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. Radiology. 2009;252:247–54.CrossRefPubMed Uto T, Takehara Y, Nakamura Y, Naito T, Hashimoto D, Inui N, Suda T, Nakamura H, Chida K. Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. Radiology. 2009;252:247–54.CrossRefPubMed
25.
Zurück zum Zitat Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size. Ann Thorac Surg. 2005;79:984–8.CrossRefPubMed Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size. Ann Thorac Surg. 2005;79:984–8.CrossRefPubMed
26.
Zurück zum Zitat Ohba Y, Nomori H, Shibata H, Kobayashi H, Mori T, Shiraishi S, Nakashima R. Evaluation of visual and semiquantitative assessments of fluorodeoxyglucose-uptake on PET Scans for the diagnosis of pulmonary malignancies 1 to 3 cm in Size. Ann Thorac Surg. 2009;87:886–91.CrossRefPubMed Ohba Y, Nomori H, Shibata H, Kobayashi H, Mori T, Shiraishi S, Nakashima R. Evaluation of visual and semiquantitative assessments of fluorodeoxyglucose-uptake on PET Scans for the diagnosis of pulmonary malignancies 1 to 3 cm in Size. Ann Thorac Surg. 2009;87:886–91.CrossRefPubMed
27.
Zurück zum Zitat Wang J, Takashima S, Takayama F, Kawakami S, Saito A, Matsushita T, Momose M, Ishiyama T. Head and neck lesions: characterization with diffusion weighted echo-planar MR imaging. Radiology. 2001;220:621–30.CrossRefPubMed Wang J, Takashima S, Takayama F, Kawakami S, Saito A, Matsushita T, Momose M, Ishiyama T. Head and neck lesions: characterization with diffusion weighted echo-planar MR imaging. Radiology. 2001;220:621–30.CrossRefPubMed
Metadaten
Titel
Comparing diffusion-weighted imaging and positron emission tomography for pulmonary nodules measuring from 1 to 3 cm in size
verfasst von
Hiroaki Nomori
Yue Cong
Hiroshi Sugimura
Yoshiaki Kato
Publikationsdatum
01.12.2015
Verlag
Springer Japan
Erschienen in
Surgery Today / Ausgabe 12/2015
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-015-1117-3

Weitere Artikel der Ausgabe 12/2015

Surgery Today 12/2015 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 49 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Wie der Klimawandel gefährliche Pilzinfektionen begünstigt

24.05.2024 Candida-Mykosen Nachrichten

Dass sich invasive Pilzinfektionen in letzter Zeit weltweit häufen, liegt wahrscheinlich auch am Klimawandel. Ausbrüche mit dem Hefepilz Candida auris stellen eine zunehmende Gefahr für Immungeschwächte dar – auch in Deutschland.

Für erste Kopie der Patientenakte sollen Ärzte kein Geld mehr erhalten

Praxen und Kliniken müssen die erste Kopie einer Patientenakte künftig kostenlos zur Verfügung stellen. Die bisherige Regelung, die noch eine Vergütung vorsieht, wird geändert.

So wirken verschiedene Alkoholika auf den Blutdruck

23.05.2024 Störungen durch Alkohol Nachrichten

Je mehr Alkohol Menschen pro Woche trinken, desto mehr steigt ihr Blutdruck, legen Daten aus Dänemark nahe. Ob es dabei auch auf die Art des Alkohols ankommt, wurde ebenfalls untersucht.

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.